2026 Q2 East Asia Reinsurance Briefing

Life & Health Reinsurance · K-ICS · Capital Quality · Block & Flow Reinsurance

Executive Summary

Korea’s insurance sector entered 2026 with improved headline K-ICS ratios, but regulatory attention is increasingly shifting from the total solvency ratio toward capital quality, actuarial governance and the effectiveness of risk management.

At the same time, reinsurance activity across East Asia is expanding beyond traditional mortality protection. Recent transactions in Hong Kong and Japan illustrate the growing use of block and flow reinsurance to transfer long-duration insurance, market and policyholder-behaviour risks and to support new business growth.

For Korean insurers, the implication is not simply to replicate overseas structures. The starting point should be to identify the actual K-ICS capital drivers and determine which risks can be economically and effectively transferred through reinsurance.

1. K-ICS: From Headline Solvency to Capital Quality

At the end of March 2026, the Korean insurance industry’s average K-ICS ratio improved. However, regulatory attention is expanding beyond the headline solvency ratio toward the adequacy of basic capital and the effectiveness of insurers’ underlying risk-management capabilities.

Overall K-ICS ratio after transitional measures: 216.1% (+3.8%p QoQ)
Life insurers: 207.7% (+1.8%p)
Non-life insurers: 229.7% (+7.8%p)
Overall K-ICS ratio before transitional measures: 202.6% (+5.0%p)

Available capital after transitional measures increased by KRW 26.9 trillion from the previous quarter, supported by net income and higher other comprehensive income associated with rising equity prices. Required capital increased by KRW 10.1 trillion, driven in part by higher equity risk charges.

From 2027, Korea will introduce a separate supervisory standard requiring a basic-capital K-ICS ratio of 50%, calculated as basic capital divided by required capital. A nine-year transitional period through the end of 2035 will apply to prompt corrective action for insurers falling below the 50% threshold.

Reinsurance differs fundamentally from capital instruments. It does not directly add available capital; rather, where substantive risk transfer is recognized, it can reduce the required capital associated with the risks transferred.

GRL View: Improving the headline K-ICS ratio is not the same as strengthening loss-absorbing basic capital or reducing the underlying risks that consume capital. From 2027 onward, this distinction is likely to become increasingly important.

2. Actuarial Assumptions, Internal Models & ORSA: A Greater Focus on Risk Management Quality

In June 2026, Korean financial authorities announced measures aimed at improving the reliability of insurance liability valuation and establishing a framework for the use of internal models under K-ICS. The direction is clear: supervisors are placing greater emphasis not only on the numbers themselves, but also on how those numbers are produced, governed and used.

Assumption Governance: Stronger standards for methodology, documentation and internal controls around key actuarial assumptions, including loss-ratio assumptions for new coverages and renewable non-indemnity products, as well as expense inflation.
K-ICS Internal Model: Approval standards covering statistical adequacy, independent validation, documentation and use of internal models in management decision-making.
ORSA: Clearer scope and responsibilities for boards and senior management under the Own Risk and Solvency Assessment framework, with possible implementation deferrals for certain smaller insurers and foreign branches.

Reinsurance Implication: When assessing structured reinsurance, the analysis should extend beyond a single-point improvement in the K-ICS ratio. Stress sensitivity, earnings volatility, counterparty risk, ORSA implications and long-term economics should also form part of the assessment.

3. East Asia Transactions: Hong Kong & Japan

In Japan and Hong Kong, the role of reinsurance is expanding beyond traditional mortality protection toward the restructuring of long-duration liabilities, the transfer of market, interest-rate and insurance risks, and support for new business growth.

Market/Period	Portfolio	Structure	Disclosed/Purpose
Hong Kong · 2026 Q2	Participating Whole Life (2 in-force transactions)	In-force Block Reinsurance	Market · Policyholder Behaviour · Mortality / Support for long-term policyholder dividends
Japan · 2026 Q2	Japanese Life Insurance Market / Broad Product & Risk Profiles	Flow Reinsurance	Ongoing reinsurance structure supporting new business / Detailed treaty economics not disclosed
Japan · 2025	Anshin Life / Whole Life · approx. US$1bn	Coinsurance / Funds Transferred	Interest Rate · Policyholder Behaviour · Mortality / Response to Japan’s transition to economic-value-based solvency regulation
Hong Kong · 2025	Leading HK Life Insurer / Participating Whole Life & Annuity · approx. US$1bn	Coinsurance / Funds Transferred	Market · Policyholder Behaviour · Mortality / Guaranteed-benefit risk transfer

Block Reinsurance: A structure under which insurance, market and policyholder-behaviour risks associated with an existing in-force portfolio are transferred or shared with a reinsurer. Depending on the transaction, objectives may include capital management, ALM and legacy risk management.

Flow Reinsurance: A structure under which a defined share of eligible new business is ceded on an ongoing basis. It can be used to share with the reinsurer the risks and capital requirements associated with future new business growth.

4. Potential Applications in the Korean Market

Rather than replicating overseas transactions, Korean insurers should first identify the actual K-ICS capital drivers within their portfolios and then assess which reinsurance structures are appropriate for the risks concerned.

Use Case 01 — Morbidity YRT / Quota Share

For long-term health and protection portfolios, morbidity and accident risks may be transferred to a reinsurer, with the potential to reduce the associated K-ICS risk charge where regulatory risk-mitigation requirements are satisfied.

Use Case 02 — Block Reinsurance

For long-duration in-force portfolios, insurers can first identify the actual capital drivers—including insurance, interest-rate and policyholder-behaviour risks—and then assess whether block reinsurance can be used to restructure the relevant risk and capital profile.

Use Case 03 — Flow Reinsurance

For annuity, savings and other long-duration new business, insurers can assess whether the risks and capital requirements associated with future production can be shared with a reinsurer from the product-development stage.

Use Case 04 — Mass Lapse Reinsurance

For portfolios with material mass-lapse exposure, insurers can assess the feasibility of substantive lapse-risk transfer together with pricing and the potential recognition of risk mitigation under K-ICS.

A Seven-Step Framework for Structured Reinsurance

Identify the K-ICS capital drivers
Analyze stress sensitivity
Define the risks to be substantively transferred
Design the treaty structure and pricing
Assess the impact on both total K-ICS and basic-capital K-ICS ratios
Evaluate earnings, counterparty and concentration risks
Document the basis for risk transfer and regulatory recognition

5. Q2 Takeaway

The message from Q2 2026 is not that “reinsurance creates capital.”

In Korea, the introduction of the basic-capital requirement makes the distinction between raising additional capital and reducing the risks that consume capital increasingly important.

At the same time, block and flow reinsurance are expanding as actual market transactions for long-duration life insurance liabilities in Japan and Hong Kong.

For Korean insurers, the objective should not be to replicate overseas structures, but to decompose their own K-ICS capital drivers and select the form of risk transfer that best matches those risks.

Sources & Reference Documents

Technical Note: The K-ICS impact of reinsurance depends on the economic substance of the contract, the scope of substantive risk transfer, reinsurer credit risk, collateral and settlement arrangements, pricing, and regulatory recognition of risk mitigation. The overseas transactions referenced in this report are based on publicly available information; no assumptions are made regarding undisclosed treaty mechanics or the capital impact on individual companies.